🇮🇹 LONCASTUXIMAB TESIRINE in Italy

LONCASTUXIMAB TESIRINE (LONCASTUXIMAB TESIRINE) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Zynlonta
  • Status: approved

LONCASTUXIMAB TESIRINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Italy

Frequently asked questions

Is LONCASTUXIMAB TESIRINE approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for LONCASTUXIMAB TESIRINE in Italy?

Marketing authorisation holder not available in our data.